[1] Weetman AP. An update on the pathogenesis of Hashimoto's thyroiditis [J]. J Endocrinol Invest, 2021, 44(5): 883-890. DOI: 10.1007/s40618-020-01477-1.
[2] Ralli M, Angeletti D, Fiore M, et al. Hashimoto's thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation [J]. Autoimmun Rev, 2020, 19(10): 102649. DOI: 10.1016/j.autrev.2020.102649.
[3] Ragusa F, Fallahi P, Elia G, et al. Hashimoto's thyroiditis: Epidemiology, pathogenesis, clinic and therapy [J]. Best Pract Res Clin Endocrinol Metab, 2019, 33(6): 101367. DOI: 10.1016/j.beem.2019.101367.
[4] Qiu K, Li K, Zeng T, et al. Integrative analyses of genes associated with Hashimoto's thyroiditis [J]. J Immunol Res, 2021: 8263829. DOI: 10.1155/2021/8263829.
[5] Klubo-Gwiezdzinska J, Wartofsky L. Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment [J]. Pol Arch Intern Med, 2022, 132(3): 16222. DOI: 10.20452/pamw.16222.
[6] Kaličanin D, Brčić L, Ljubetić K, et al. Differences in food consumption between patients with Hashimoto's thyroiditis and healthy individuals [J]. Sci Rep, 2020, 10(1): 10670. DOI: 10.1038/s41598-020-67719-7.
[7] Dwivedi SN, Kalaria T, Buch H. Thyroid autoantibodies [J]. J Clin Pathol, 2023, 76(1): 19-28. DOI: 10.1136/jcp-2022- 208290.
[8] 谭艳仙,陈晓青,黎清凤. 血清TgAb、TPOAb联合检测诊断桥本甲状腺炎的价值研究[J]. 中国卫生标准管理,2022,13(17):115-119. DOI:10.3969/j.issn.1674-9316. 2022.17.025.
[9] Bílek R, Dvořáková M, Grimmichová T, et al. Iodine, thyroglobulin and thyroid gland [J]. Physiol Res, 2020, 69 Suppl 2: S225-S236. DOI: 10.33549/physiolres.934514.
[10] Mammen JSR, Cappola AR. Autoimmune thyroid disease in women [J]. JAMA, 2021, 325(23): 2392-2393. DOI: 10.1001/jama.2020.22196.
[11] 张国玉,万会娜,郭盼盼,等. 桥本甲状腺炎发病因素及发病机制研究进展[J]. 新乡医学院学报,2020,37(10):984-989,995. DOI:10.7683/xxyxyxb.2020.10.019.
[12] 李堂. 桥本甲状腺炎的发病机制与诊治进展[J]. 实用儿科临床杂志,2012,27(8):563-565. DOI:10.3969/j.issn.1003- 515X.2012.08.004.
[13] 刘莹,李昀昊,杨宏杰. 桥本甲状腺炎发病机制研究进展[J]. 长春中医药大学学报,2017,33(4):686-688. DOI:10.13463/j.cnki.cczyy.2017.04.059.
[14] Zhang Q, Zhang S, Pan Y, et al. Deep learning to diagnose Hashimoto's thyroiditis from sonographic images [J]. Nat Commun, 2022, 13(1):3759. DOI: 10.1038/s41467-022-31449-3.
[15] 吕青松,凡慧慧,倪艺芸. TPOAb与TGAb联合检测对桥本甲状腺炎的诊断价值[J]. 临床医学工程,2018,25(5):607-608. DOI:10.3969/j.issn.1674-4659.2018.05.0607.
[16] 谢军,褚玲,刘娟. 联合检测TPOAb、TGAb在诊断桥本甲状腺炎中的临床价值研究[J]. 国际检验医学杂志,2017,38(23):3330-3332. DOI:10.3969/j.issn.1673-4130. 2017.23.042.
[17] 刘丽华,吴斯淳,李晓静. 桥本甲状腺炎患者血清甲状腺过氧化物酶抗体和甲状腺球蛋白抗体表达水平及诊断意义[J]. 实用医院临床杂志,2020,17(6):175-178. DOI:10.3969/j.issn.1672-6170.2020.06.052.
[18] Alexander LF, Patel NJ, Caserta MP, et al. Thyroid ultrasound: diffuse and nodular disease [J]. Radiol Clin North Am, 2020, 58(6): 1041-1057. DOI: 10.1016/j.rcl.2020.07.003.
[19] 张永选. 血清TPOAb、TGAb、TRAb水平检测对Graves病及桥本甲状腺炎的诊断价值分析[J]. 四川解剖学杂志,2020,28(3):173-174. DOI:10.3969/j.issn.1005-1457. 2020.03.083.
|